Chemkart India IPO will open on July 7, 2025, and close on July 9, 2025. This is a Book Build Issue, through which the company plans to raise approximately ₹80.08 crores. The IPO includes a fresh issue of ₹64.48 crores and an offer for sale of up to 6,29,200 equity shares, each having a face value of ₹10.
The price band for the Chemkart India IPO is set at ₹236 to ₹248 per share. The retail investor quota is 35%, Qualified Institutional Buyers (QIB) have a 50% allocation, and High Net-worth Individuals (HNI) are allocated 15%. The IPO is expected to be listed on BSE on July 14, 2025, while the allotment date is July 10, 2025.
In terms of financial performance, the company reported a revenue of ₹205.46 crores in 2025, up from ₹132.83 crores in 2024. Its profit increased to ₹24.26 crores in 2025, compared to ₹14.52 crores in 2024.
Chemkart India IPO Date & Price Band Details
| Category | Details |
|---|---|
| IPO Open Date: | July 7, 2025 |
| IPO Close Date: | July 9, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹236 to ₹248 Per Share |
| Issue Size: | Approx ₹80.08 Crores |
| Fresh Issue: | Approx ₹64.48 Crores |
| Offer for Sale: | Approx 6,29,200 Equity Shares |
| Issue Type: | Book Build Issue |
| IPO Listing: | BSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Chemkart India Company Overview, Strengths, and Risks
Chemkart India Private Limited is a Mumbai-based company established in 2015 (though some sources mention 2020 for the private limited entity). It operates primarily as a B2B importer, manufacturer, and wholesale supplier of high-quality Food and Nutraceutical Ingredients in India. They also have an international presence in Asia, Africa, and the Middle East.
Chemkart India Company Overview:
- Founded: 2015 (as a proprietorship, with the Private Limited company incorporated in 2020).
- Headquarters: Mumbai, Maharashtra, India.
- Business Model: Primarily a B2B distributor and a manufacturer (of processed goods like blends). They bridge the gap between global ingredient manufacturers (mainly from Europe, US, and China) and businesses in the Food and Health Ingredients Industry.
- Product Categories: They offer a diverse range of products across seven primary categories:
- Amino Acids (e.g., Arginine Aspartate, L-Arginine HCL)
- Health Supplements
- Herbal Extracts
- Nucleotides
- Proteins
- Sports Nutrition
- Vitamins
- Sweeteners
- Novel Ingredients
- Infrastructure: They operate a processing and warehousing unit in Bhiwandi, Maharashtra, spanning over 28,000 sq. ft., equipped for blending, grinding, packaging, labeling, and sealing nutraceutical ingredients.
- Certifications: FSSAI licenses for warehouse and registered office, Halal certification from GACB, and ISO 9001:2015 for quality management.
- Clientele: They cater to manufacturers of dietary supplements, sports nutrition products, and health formulations in both domestic and international markets.
- Financials (as of FY25):
- Revenue: INR 205.46 crores (FY25)
- Profit After Tax: INR 24.26 crores (FY25)
- Employee Count: 29 (as of May 2025)
Strengths:
- Diversified Product Portfolio: Chemkart offers a wide range of essential and specialized ingredients across multiple categories, catering to diverse needs within the health and nutrition industry. This diversification reduces reliance on a single product segment.
- In-House Processing and Warehousing Capabilities: Their Bhiwandi facility allows them to provide value-added services like blending, grinding, and custom packaging, which enhances their appeal to customers seeking tailored solutions.
- Strong Value Proposition for Customers: By focusing on quality sourcing, transparent operations, and reliable supply chain management, Chemkart positions itself as a trusted partner for businesses, simplifying their ingredient procurement.
- Customer-Centric Approach and Relationships: The company emphasizes building long-term relationships with its B2B clients, which can lead to repeat orders and stable revenue streams.
- Quality Assurance: Their commitment to quality is evident through sourcing from FDA/GMP approved factories and in-house laboratory testing of all products. They also hold relevant industry certifications (FSSAI, Halal, ISO).
- Growth in a Booming Industry: They operate in the rapidly growing Indian health and wellness sector, driven by increasing health consciousness, rising disposable incomes, and the penetration of online wellness brands.
- Experienced Management Team: The company is led by experienced professionals in the chemical and nutraceutical industries, including Ankit Mehta (Founder, Chairman, and Managing Director).
Risks:
- High Dependence on Key Suppliers: Chemkart India relies significantly on a limited number of top international suppliers for its raw materials, particularly from China, the US, and Europe. They do not have long-term or exclusive supply agreements with these suppliers, making them vulnerable to disruptions, price fluctuations, or discontinuation of supply.
- Import-Driven Supply Chain: A major portion of their products are imported. This exposes them to risks associated with global trade policies, currency fluctuations, import duties, and geopolitical events.
- Customer Concentration: While they aim for a wide customer network, their revenue heavily depends on certain key customers. Loss of one or more major clients or a reduction in their demand could significantly impact revenue and profitability.
- Lack of Long-Term Customer Contracts: Chemkart primarily relies on purchase orders rather than long-term contracts with its customers. This means customers can cancel or modify orders, change quantities, or delay payments, creating revenue uncertainty.
- Limited Branding and Low IP Ownership: Their primarily trading-based business model, with a small fraction from processed goods, suggests limited brand equity and intellectual property. This could cap long-term margin expansion and differentiation in a competitive market.
- Regulatory Compliance Risks: While they hold FSSAI and Halal certifications, any discrepancies or delays in corporate record filings or non-compliance with regulations could lead to penalties and impact their financial position.
- Competition: The market for food and nutraceutical ingredients is competitive, with other distributors and online marketplaces vying for market share. Sustaining competitive differentiation requires continuous innovation and value addition.
- Working Capital Management: A trading-heavy model often requires efficient working capital management to handle inventory and receivables, which can be a challenge.
In summary, Chemkart India has built a strong position in the Indian nutraceutical ingredients market by offering a diverse product portfolio and value-added services. However, its reliance on a few international suppliers and key customers, along with the nature of a trading-heavy business, presents notable risks that the company needs to manage for sustainable long-term growth.
Chemkart India IPO Market Lot
The Chemkart India IPO minimum market lot is 600 shares, requiring a total application amount of ₹1,48,800 for retail investors.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 600 | ₹1,48,800 |
| Retail Maximum | 1 | 600 | ₹1,48,800 |
| S-HNI Minimum | 2 | 1,200 | ₹2,97,600 |
Chemkart India IPO New Market Lot
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 1,200 | ₹2,97,600 |
| Retail Maximum | 2 | 1,200 | ₹2,97,600 |
| S-HNI Minimum | 3 | 1,800 | ₹4,46,400 |
Chemkart India IPO Allotment & Listing Dates
The Chemkart India IPO will open on July 7 and close on July 9, 2025. The IPO allotment is expected to be finalized on July 10, and the listing will take place on the BSE on July 14, 2025.
| Type | Date |
|---|---|
| IPO Open Date: | July 7, 2025 |
| IPO Close Date: | July 9, 2025 |
| Basis of Allotment: | July 10, 2025 |
| Refunds: | July 11, 2025 |
| Credit to Demat Account: | July 11, 2025 |
| IPO Listing Date: | July 14, 2025 |
Chemkart India IPO: Promoters
The promoters of Chemkart India are Mr. Ankit Shaileesh Mehta, Ms. Parul Shaileesh Mehta, and Mr. Shaileesh Vinodrai Mehta.
Chemkart India IPO Company Financial Report
The company reported a revenue of ₹205.46 crores in FY 2025, a significant rise from ₹132.83 crores in FY 2024. Similarly, the net profit increased to ₹24.26 crores in FY 2025, compared to ₹14.52 crores in FY 2024.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
|---|---|---|---|---|
| 2022 | ₹87.43 | ₹80.11 | ₹5.48 | ₹24.54 |
| 2023 | ₹131.69 | ₹121.17 | ₹7.66 | ₹37.48 |
| 2024 | ₹132.83 | ₹112.87 | ₹14.52 | ₹53.51 |
| 2025 | ₹205.46 | ₹172.86 | ₹24.26 | ₹86.12 |
Chemkart India IPO Valuation – FY2025
| KPI | Values |
|---|---|
| ROE: | 0.59 |
| ROCE: | 0.49 |
| EBITDA Margin: | 16.12% |
| PAT Margin: | 0.12 |
| Debt to equity ratio: | 0.32 |
| Earning Per Share (EPS): | ₹25.54 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 45.52% |
| Net Asset Value (NAV): | ₹56.10 |
Chemkart India IPO Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| NA | – | – | – | – | – Cr. |
Objects of the Issue – Chemkart India IPO
The net proceeds from the Chemkart India IPO will be utilized for the following purposes:
- Financing capital expenditure towards the establishment of a manufacturing facility through investment in the Wholly-Owned Subsidiary (WOS), Easy Raw Materials Private Limited
- Repayment or prepayment of all or part of the borrowings availed by the company
- General corporate purposes
Chemkart India IPO Review
- Canara Bank
- DRChoksey FinServ
- Emkay Global
- Hem Securities
- IDBI Capital
- Marwadi Shares
- Nirmal Bang
- SBICAP Securities
- Sharekhan
- SMC Global
- Sushil Finance
- Swastika Investmart
- Ventura Securities
- Geojit
- Reliance Securities
- Capital Market
- BP Wealth
- ICICIdirect
- Choice Broking
Chemkart India IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Chemkart India IPO Lead Managers aka Merchant Bankers
- Smart Horizon Capital Advisors Private Limited
Chemkart India Company Address
Chemkart India Limited
Office No. 403/404,
4th Floor, K.L. Accolade, 6th Road,
TPS III, Santacruz (East), Mumbai – 400055
Mumbai, Maharashtra
Phone: +91 9136383828
Email: investors@chemkart.com
Website: https://chemkart.com/
FAQs about Chemkart India IPO
The Chemkart India IPO will open for subscription on July 7, 2025, and will close on July 9, 2025.
The Chemkart India IPO price band is set at ₹236 to ₹248 per equity share.
The minimum Chemkart India Lot Size for retail investors is 1,200 shares, requiring an investment of ₹2,97,600 at the upper price band. The maximum lot size for retail investors is also 1,200 shares.
The Chemkart India IPO is expected to be listed on BSE SME on July 14, 2025.
The total issue size of the Chemkart India IPO is approximately ₹80.08 crores, consisting of a fresh issue of ₹64.48 crores and an Offer for Sale of up to 6,29,200 equity shares.
Chemkart India primarily operates as a B2B importer, manufacturer, and wholesale supplier of high-quality Food and Nutraceutical Ingredients in India. They bridge the gap between global ingredient manufacturers and Indian businesses in the food and health industries, also offering in-house processing and warehousing for blending, grinding, and packaging.
Chemkart India has shown strong financial growth. For FY2025, the company reported a revenue of ₹205.46 crores, a significant increase from ₹132.83 crores in FY2024. Their profit after tax also rose to ₹24.26 crores in FY2025, up from ₹14.52 crores in FY2024.
The promoters of Chemkart India are Mr. Ankit Shaileesh Mehta, Ms. Parul Shaileesh Mehta, and Mr. Shaileesh Vinodrai Mehta.
The net proceeds from the IPO will be utilized for financing capital expenditure towards establishing a manufacturing facility through its Wholly-Owned Subsidiary (Easy Raw Materials Private Limited), repayment or prepayment of certain borrowings, and general corporate purposes.
The Chemkart India IPO Subscription status will be updated daily during the bidding period on various financial news platforms. The basis of allotment is expected to be finalized on July 10, 2025. You can typically check the allotment status on the website of the IPO registrar, Bigshare Services Pvt Ltd, once it is finalized.
